Robert H Mealey Selected Research

imidocarb dipropionate

1/2015	Theileria equi isolates vary in susceptibility to imidocarb dipropionate but demonstrate uniform in vitro susceptibility to a bumped kinase inhibitor.
1/2012	Re-emergence of the apicomplexan Theileria equi in the United States: elimination of persistent infection and transmission risk.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert H Mealey Research Topics

Disease

10	Infections 01/2018 - 12/2004
3	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2018 - 07/2011
3	Viremia 05/2015 - 12/2004
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Fibrosis (Cirrhosis) 01/2018
1	Parasitic Diseases (Parasitic Disease) 09/2017
1	Liver Diseases (Liver Disease) 05/2015
1	Inflammation (Inflammations) 05/2015
1	Equine Infectious Anemia (Swamp Fever) 12/2014
1	Vaccinia 04/2009

Drug/Important Bio-Agent (IBA)

4	AntibodiesIBA 01/2018 - 07/2010
3	Neutralizing AntibodiesIBA 01/2018 - 12/2004
3	VaccinesIBA 12/2014 - 04/2009
3	Proteins (Proteins, Gene)FDA Link 11/2013 - 12/2004
2	EnzymesIBA 05/2015 - 11/2013
2	imidocarb dipropionateIBA 01/2015 - 01/2012
1	Phosphotransferases (Kinase)IBA 09/2017
1	Protein Kinases (Protein Kinase)IBA 09/2017
1	ImmunosorbentsIBA 11/2013
1	Immunoglobulins (Immunoglobulin)IBA 07/2011
1	Broadly Neutralizing AntibodiesIBA 07/2010
1	Codon (Codons)IBA 04/2009
1	DNA (Deoxyribonucleic Acid)IBA 04/2009
1	Immunoglobulin G (IgG)IBA 04/2009
1	EpitopesIBA 11/2005

Therapy/Procedure

1	Therapeutics 09/2017